IracetTM 250 Tablet: Each tablet contains Levetiracetam USP 250 mg.
IracetTM 500 Tablet: Each tablet contains Levetiracetam USP 500 mg.
IracetTM Injection: Each 5 ml Ampoule contains Levetiracetam USP 500 mg.
IracetTM Oral solution: Each 5 ml solution contains Levetiracetam USP 500 mg.
IracetTM (Levetiracetam) The exact mechanism of action is unknown but does not involve inhibitory and excitatory
neurotransmission. Stereo-selective binding of Levetiracetam was confined to synaptic plasma membranes in the
central nervous system with no binding occurring in peripheral tissue.
IracetTM (Levetiracetam) is indicated as an adjunctive therapy for:
.Partial Onset Seizures
.Myoclonic Seizures In Patients with Juvenile Myoclonic Epilepsy
.Primary Generalized Tonic-Clonic Seizures
IracetTM (Levetiracetam) injection is an alternative for adult patients (16 years and older) when oral administration is temporarily not feasible.
Dosage & Administration
IracetTM (Levetiracetam) can be initiated with either intravenous or oral administration.
For tablet and oralsolution
Treatment should be initiated with a daily dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily).
Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended
daily dose of 3000 mg.
Only logged in customers who have purchased this product may leave a review.